The innovative transcatheter mitral bio-prosthesis
Epygon valve is conceived to match the hemodynamic and anatomic features of the native mitral valve.
Our ambition is to design a mitral bioprosthesis with excellent clinical outcomes in patients with severe mitral regurgitation, specially when poor left ventricular function is present and mitral valve replacement is mandatory.
The key features of Epygon valve such as D-shape annular ring, monoleaflet, asymmetric stent and anatomic anchoring are granting a physiologic hemodynamics, optimal annulus fitting and low risk of LVOT obstruction.
D-shape annular ring
It minimizes the risk of perivalvular leak and LVOT obstruction (possible with round oversized trileaflet valves)
Physiologic diastolic asymmetric flow towards the posterior wall to get an optimal LV filling and low pressure gradients
Physiologic systolic flow acceleration of the blood into the aorta
High tolerance towards paravalvular leakages, intra-prosthetic regurgitation and possible leaflets’ blockage caused by stent deformation during the cardiac cycle (it is possible with inverted aortic prostheses)
The stent is shorter in anterior portion minimizing the risk of LVOT obstruction and deformation of the aortic root
The bioprosthesis is manufactured by a self-expandable Nitinol stent and bovine pericardial monoleaflet (no or minimal use of polyester fabric to reduce risk of thrombosis and endocarditis)
Anatomic atraumatic anchoring system
The Epygon bioprosthesis is anchored to the native mitral valve structures with protected extension bodies
The valve is provided with a capturing system for the anterior leaflet preventing LVOT obstruction due to SAM
Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.